Internet-Adressen:
Website http://hiru.mcmaster.ca/cochrane/default.htm
Für den deutschsprachigen Raum:
http://www.imbi.uni-freiburg.de/cochrane
http://www.iawf.unibe.ch/cochrane/index.htm
Mailing-Liste:
email gant@amil.ukl/uni-freiburg.de
The United Kindom Cochrane Center
NHS Research and Development
Programme
Summertown Pavillion
Middle Way,
Oxford, UK
Telefon: 44-1865-516300
Fax: 44-1865-516311
Email: general@cochrane.co.uk
ACP Journal Club
zu beziehen bei:
American College of Physicians
Independence Mall West
Sixth Street at Race
Philadelphia, PA 19106-1572 USA
Evidence Based Medicine
zu beziehen bei:
American College of Physicians and
BMJ Publishing Group
Tavistock Square
London WC1H 9JR, UK
Infomed Screen
Infomed-Verlag
Postfach 528
9501 Wil
Medline:
Kommerzielle Anbieter für CD-ROM wie Silverplatter, Ovid oder Online-Anbieter wie Datastar oder Compuserve
Online-Anbieter mit Internet:
http://www.healthgate.com
(Monatsprämie US $ 14.95)
Melamed M. R., Flehinger B. J., Zaman M. B. et al.: Screening for early lung cancer. Results of the Memorial Sloan-Kettering study in New York. Chest 1984; 86: 4453.
Ball W. E. C., Frost J. K., Tockman M. E. et al.: Screening for lung cancer: the effect of 5-7 years periodic roentgenographic and cytologic examinations on detection survival and mortality from lung cancer. Am Rev Respir Dis 1985; 131: A84.
Fontana R. S., Sanderson D. R., Wollner L. B. et al.: Lung cancer screening: the Mayo program.
J Occup Med 1986; 28: 46-750.Cummings S. R., Nevitt M. C., Browner W. S., Stone K., Fox K. M., Ensrud K. E. et al.: Risk factors for hip fracture in white women. N Engl J Med 1995; 332: 767-73.
Canadian Task Force on the Periodic Health Examination. The Canadian guide to clinical preventive health care. Minister of Supply and Services No. H21-1171994E Ottawa 1994.
Enkin M., Keirse M. J. N. C., Chalmers I. (eds): A guide to effective care in pregnancy and childbirth. Oxford, Oxford University Press 1995.
Sinclair J. C., Bracken M. B. (eds): Effectiveness care of the newborn infant. Oxford, Oxford University Press, 1992.
Rosenberg W., Donald A.: Evidence based medicine: an approach to clinical problem solving BMJ 1995; 310: 1122-6.
Antman E. M., Lau J., Kupelnick B., Mosteller F., Chalmers T. C.: A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. JAMA 1992; 268: 240-248.
Egger M., Davey Smith G.: Misleading meta-analysis. BMJ 1995; 310: 752-4.
Arbeitsgemeinschaft Cochrane Collaboration. Die Cochrane Collaboration. Schweiz. Ärztezeitung 1996; 77: 117-120.
Chalmers I., Haynes B.: Reporting, updating, and correcting systematic reviews of the effects of health care. BMJ 1994; 309: 862-5.
Bero L., Rennie D.: The Cochrane Collaboration. JAMA 1995; 274: 1935-1938.
SPAF Investigators. Predictors of thromboembolism in atrial fibrillation. I. Clinical features in patients at risk. Ann Intern Med 1992; 116: 1-5.
SPAF Investigators. Predictors of thromboembolism in atrial fibrillation. II. Echocardiographic features in patients at risk. Ann Intern Med 1992; 116: 6-12.
Petersen P., Boysen G., Godtfredsen J., Andersen E. D., Andersen B.: Placebo controlled randomised trial of warfarin and aspirin for the prevention of thrombo-embolic complications in chronic atrial fibrillation. Lancet 1989; i: 175-9.
Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effet of low-dose warfarin on the risk of stroke in patients with non-rheumatic atrial fibrillation. N Engl J Med 1990; 323: 1505-11.
Stroke Prevention in Atrial Fibrillation Investigators. Stroke prevention in atrial fibrillation study: final results. Circulation 1991; 84: 527-39.
Ezekowitz M. D., Bridgers S. L., James K. E., Carliner N. H., Colling C. L., Gormick C. C. et al.: Warfarin in the prevention of stroke associated with non-rheumatic atrial fibrillation. N Engl J Med 1992; 347: 1406-12.
Connolly S. J., Laupacis A. , Gent M., Roberts R. S., Cairns J. A., Joyner C.: Canadian atrial fibrillation anticoagulation (CAFA) study. J Am Coll Cardio 1991; 18: 349-55.
Stroke Prevention in Atrial Fibrillation Investigators. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: stroke prevention in atrial fibrillation II study. Lancet 1994; 343: 687-91.
European Atrial Fibrillation Trial Study Group. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet 1993; 342: 155-62.
Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Arch Intern Med 1994; 154: 1449-57.
David L. Sackett, R. Brian Haynes, Gordon H. Guyatt, Peter Tugwell.: Clinical Epidemiology, a bassic science for clinical medicine. Little. Brown, Boston 1991.
Oxman A. D., Sackett D. L., Guyatt G. H. et al. for the Evidence-Based Medicine Working Group: User's Guide to the Medical Literature: I. How to Get Started. JAMA 1993; 270: 2093-95.
Guyatt G. H., Sackett D. L., Cook D. J. et al. for the Evidence-Based Medicine Working Group: User's Guide to the Medical Literature. II How to Use an Article About Therapy or Prevention. Are the Results of the Study Valid? JAMA 1993; 270: 2598-2601.
Jaschke R., Guyatt G. H., Sackett D. L. et al. for the Evidence-Based Medicine Working Group: User's Guide to the Medical Literature. III How to Use an Article About a Diagnostic Test. A. Are the Results of the Study Valid? JAMA 1994; 271: 389-91.
Jaschke R., Guyatt G. H., Sackett D. L. et al. for the Evidence-Based Medicine Working Group. User's Guides to the Medical Literature. III How to Use an Article About a Diagnostic Test. B. What Are the Results and Will They Help Me to in Caring for My Patients? JAMA 1994; 271: 703-7.
Levine M., Walter S., Hui L., Haines T., Holbrook A., Moyer V. for the Evidence-Based Medicine Working Group: Users' Guides to the Medical Literature: IV How to Use an Article About Harm. JAMA 1994; 271: 1615-19.
Laupacis A., Wells G., Richardson S., Tugwell P. for the Evidence-Based Medicine Working Group: Users' Guides to the Medical Literature: V How to Use an Article About Prognosis. JAMA 1994; 272: 234-7.
Oxman A. D., Cook D. J., Guyatt G. H. for the Evidence-Based Medicine Working Group: Users' Guides to the Medical Literature: VI How to Use an Overview. JAMA 1994; 272: 1367-71.
Richardson W. S., Detsky A. S. for the Evidence-Based Medicine Working Group: Users' Guides to the Medical Literature: VII How to Use a Clinical Decision Analysis. A. Are the Results of the Study Valid? JAMA 1995; 273: 1292-5.
Richardson W. S., Detsky A. S. for the Evidence-Based Medicine Working Group: Users' Guides to the Medical Literature: VII How to Use a Clinical Decision Analysis. B. What Are the Results and Will They Help Me in Caring for My Patients? JAMA 1995; 273: 1610-3.
Hayward R., Wilson M. C., Tunis S. R., Bass E. B., Guyatt G. H. for the Evidence-Based medicine Working Group: Users' Guides to the Medical Literature. VIII How to Use Clinical Practice Guidelines. A. Are the Recommendations Valid? JAMA 1995; 274: 570-4.
Wilson M. C., Hayward R. S. A., Tnis S. R., Bass E. B., Guyatt G. H. for the Evidence-Based Medicine Working Group: Working Group. Users' Guides to the Medical Literature. VIII How to Use Clinical Practice Guidelines. B. What Are the Recommendations and Will They Help You in Caring for Your Patients? JAMA 1995; 274: 1630-2.
Bucher H., Gutzwiller F.: Checkliste Gesundheitsberatung und Prävention. Georg Thieme Verlag Stuttgart 1993, S.30-33.
Naylor C. D.: Grey zones of clinical practice: some limits to evidence-based medicine. Lancet 1995; 345: 840-2.
Quelle: Schweizerische Ärztezeitung, Band 77, Heft 41 vom 9.10.96, S.1660-1667.